IMPLEMENTING VIVITROL AS A CHANGE PROJECT Angela Bonaguidi, Jael Dorado, Eric Ennis (Change Team Leader), Jan Morgan, Marie Officer, Denise Vincioni, Dr. William Swafford, Greg Tipton, Ira Tropp, Addiction Research and Treatment Services, University of Colorado Denver, School of Medicine.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
IMPLEMENTING VIVITROL AS A CHANGE PROJECTAngela Bonaguidi, Jael Dorado, Eric Ennis (Change Team Leader), Jan Morgan, Marie Officer,
Denise Vincioni, Dr. William Swafford, Greg Tipton, Ira Tropp,
Addiction Research and Treatment Services, University of Colorado Denver, School of Medicine
ARTS is a comprehensive community-based substance abuse treatment program in our 38th year of operation. We have offered oral naltrexone for many years, but have seen low utilization of this pharmacologic treatment in our alcohol dependent patients. We operate 3 MAT clinic sites and 3 non-MAT clinic sites, all with some alcohol dependent patients.
Developed agency level procedures for acquisition and administration of Vivitrol, and data collection for this project
Change Team Composition:
Eric Ennis (Outpatient Director)
Dr. Bill Swafford (Medical Director)
Jan Morgan (Manager of Nursing Operations and Clinic Coordinator)
Jael Dorado (Dispensing Nurse)
Denise Vincioini (Clinic Coordinator)
Ira Tropp (Clinic Coordinator)
Marie Officer (Counselor)
Angela Bonaguidi (Counselor)
Greg Tipton (Counselor)
First Change Cycle:
How can we promote the use of depot naltrexone?
Change Team member not pictured:
Dr. Bill Swafford
More and better services with better outcomes = more referrals = more revenue flowing into program
Second Change Cycle:
How can we best identify and “qualify” patients while incentivizing staff?
Counselors identify patients who are not only interested but also eligible according to specific clear criteria